US health authorities allow Johnson & Johnson to restart coronavirus vaccination
AP
The US authorities have now recommended that Johnson & Johnson Covid vaccinations can restart, United States health regulators said on Friday. Earlier, they had called for a pause after the shots rollout was paused due to worries over blood clotting, according to news reports.
On April 14, health authorities had proposed a halt on the vaccine following instances of severe blood clots among a handful of the millions of Americans who received the vaccine.
According to
Bloomberg, the Advisory Committee on Immunization Practices voted 10 to 4, with one abstention, to back the vaccine, opening the way for the US Centers for Disease Control and Prevention and the Food and Drug Administration to lift a pause on the shot that was put in place after reports of rare, serious blood clots among recipients. Regulators put dosing with the vaccine on hold 10 days ago to gather more information
CDC Investigating New Death And Hospitalization Following Johnson & Johnson Vaccination forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson jab may cause unusual blood clotting
According to the EU agency, over 7 million people received the product of the Johnson & Johnson pharma company
BRUSSELS:
The European Medicine Agency (EMA) confirmed on Tuesday that there could be a link between Johnson & Johnson vaccines and very rare cases of blood clots.
“A warning about unusual blood clots with low blood platelets should be added to the product information for Covid-19 Vaccine Janssen,” the EU regulator announced in a statement following the investigation of its safety committee.
But the EMA upheld its recommendation to use the jabs and confirmed that its benefits outweighed possible risks.